Results from a French study on men and women treated with a variety of targeted cancer drugs show that the treatments negatively impact their sex lives. The effects were significant and both sexes were subject to this side-effect.
This study was presented at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.
Learn More